First paper of 2018 published!

Calcium activated nucleotidase 1 (CANT1) is critical for glycosaminoglycan biosynthesis in cartilage and endochondral ossification.

Paganini C, Monti L, Costantini R, Besio R, Lecci S, Biggiogera M, Tian K, Schwartz JM, Huber C, Cormier-Daire V, Gibson BG, Pirog KA, Forlino A, Rossi A.

Desbuquois dysplasia type 1 (DBQD1) is a chondrodysplasia caused by mutations in CANT1 gene encoding an ER/Golgi calcium activated nucleotidase 1 that hydrolyses UDP. Here, using Cant1 knock-in and knock-out mice recapitulating DBQD1 phenotype, we report that CANT1 plays a crucial role in cartilage proteoglycan synthesis and in endochondral ossification. Specifically, the glycosaminoglycan synthesis was decreased in chondrocytes from Cant1 knock-out mice and their hydrodynamic size was reduced, whilst the sulfation was increased and the overall proteoglycan secretion was delayed. Interestingly, knock-out chondrocytes had dilated ER cisternae suggesting delayed protein secretion and cellular stress; however, no canonical ER stress response was detected using microarray analysis, Xbp1 splicing and protein levels of BiP and ATF4. The observed proteoglycan defects caused deregulated chondrocyte proliferation and maturation in the growth plate resulting in the reduced skeletal growth. In conclusion, the pathogenic mechanism of DBQD1 comprises deregulated chondrocyte performance due to defective intracellular proteoglycan synthesis and altered proteoglycan properties in the extracellular matrix.

Congratulations Dr Beth Gibson!

Beth defended her PhD thesis on investigation of the pathomolecular mechanism of two aggrecan mutations leading to OCD and SEMD using mouse models of disease.

Thank you to Prof Frank Zaucke from Frankfurt and Dr Andy Knight from Newcastle University for examining the thesis and well done Beth, all the best in your future career!

 

4th October 2018 – Dame Allan’s Schools biennial Higher Education & Careers Convention

Dame Allan’s Schools holds a biennial Higher Education & Careers Convention and invire presenters, employers, and universities to inspire and inform their students as they make plans for their future. We’ll be there on the 4th of October, chatting about genetic research and academic life and inspiring the young minds. We’ll show some cool science too!

Our research at the Great Exhibition of the North

On Saturday the 28th of July we were presenting our bench to bedside research at the Great North Museum Hancock as part of the Great Exhibition of the North, an event celebrating innovation and excellence of science and technology in the North East. We chatted to approximately 100 people of all ages, presented out work and specimens and answered many interesting questions. Thank you all for visiting and making it a really enjoyable day!

If you missed us and would like to come see us another time, we’ll be present at Dame Allan’s Schools careers fair in October or keep an eye out for advertisements of our flagship Genetics Matters event, coming up end of February as part of the International Rare Disease Day!

Newcastle’s Skeletal Research Group at the MRC Festival of Medical Research

IGM and ICM scientists involved in the MRC funded CIMA (Centre for Integrated research into Musculoskeletal Ageing) project have organised an informative public engagement afternoon on Wednesday the 20th of June 2018 to chat to the members of the public about joints in health and disease, joint diseases and the impact of diet and exercise on joints’ health. The attendance is FREE, full programme attached below:

Our lab wins a technology prize in the 2017/18 BeHEARD competition!

The BeHEARD (Helping Empower and Accelerate Research Discoveries) Challenge is hosted annually by the Rare Genomics Institute and is open globally to researchers, foundations, or anyone whose research is constrained due to limited resources. It provides technology and financial grants for rare disease research. Families with a child afflicted with a rare disease have the opportunity to work with a network of academic researchers to develop research proposals tailored to advancing treatments for their child’s disease.

We just heard that our group won the technology prize in the 2017/18 competition. The prize is a vector constructed by Cyagen (worth $8,950) which will be used to generate a conditional knock-out mouse model that will greatly enhance our sudies of skeletal dysplasias. We are very grateful for this prize and we’re looking forward to the exciting project ahead!